Why do BCL-2 inhibitors work and where should we use them in the clinic? von Montero, Joan, Letai, Antony

Volltext

Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical Outcomes von Marusyk, Andriy, Tabassum, Doris P, Janiszewska, Michalina, Place, Andrew E, Trinh, Anne, Rozhok, Andrii I, Pyne, Saumyadipta, Guerriero, Jennifer L, Shu, Shaokun, Ekram, Muhammad, Ishkin, Alexander, Cahill, Daniel P, Nikolsky, Yuri, Chan, Timothy A, Rimawi, Mothaffar F, Hilsenbeck, Susan, Schiff, Rachel, Osborne, Kent C, Letai, Antony, Polyak, Kornelia

Volltext

Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma von Zhao, Jian-Jun, Chu, Zhang-Bo, Hu, Yu, Lin, Jianhong, Wang, Zhongqiu, Jiang, Meng, Chen, Ming, Wang, Xujun, Kang, Yue, Zhou, Yangsheng, Ni Chonghaile, Triona, Johncilla, Melanie E, Tai, Yu-Tzu, Cheng, Jin Q, Letai, Antony, Munshi, Nikhil C, Anderson, Kenneth C, Carrasco, Ruben D

Volltext

Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer von Shu, Shaokun, Lin, Charles Y., He, Housheng Hansen, Witwicki, Robert M., Tabassum, Doris P., Roberts, Justin M., Janiszewska, Michalina, Jin Huh, Sung, Liang, Yi, Ryan, Jeremy, Doherty, Ernest, Mohammed, Hisham, Guo, Hao, Stover, Daniel G., Ekram, Muhammad B., Peluffo, Guillermo, Brown, Jonathan, D’Santos, Clive, Krop, Ian E., Dillon, Deborah, McKeown, Michael, Ott, Christopher, Qi, Jun, Ni, Min, Rao, Prakash K., Duarte, Melissa, Wu, Shwu-Yuan, Chiang, Cheng-Ming, Anders, Lars, Young, Richard A., Winer, Eric P., Letai, Antony, Barry, William T., Carroll, Jason S., Long, Henry W., Brown, Myles, Shirley Liu, X., Meyer, Clifford A., Bradner, James E., Polyak, Kornelia

Volltext

Inhibition of MAPKinase pathway sensitizes thyroid cancer cells to ABT-737 induced apoptosis von Gunda, Viswanath, Sarosiek, Kristopher A, Brauner, Eran, Kim, Yon Seon, Amin, Salma, Zhou, Zhiheng, Letai, Antony, Parangi, Sareh, MD

Volltext

Abstract B24: Targeting hyaluronan sensitizes breast cancer-associated fibroblasts to lapatinib and overcomes stromal resistance von Marusyk, Andriy, Tabassum, Doris, Guerriero, Jennifer, Place, Andrew, Rozhok, Andrii, Letai, Antony, Polyak, Kornelia

Volltext

Response and resistance to BET bromodomain inhibitors in triple negative breast cancer von Shu, Shaokun, Lin, Charles Y, He, Housheng Hansen, Witwicki, Robert M, Tabassum, Doris P, Roberts, Justin M, Janiszewska, Michalina, Huh, Sung Jin, Liang, Yi, Ryan, Jeremy, Doherty, Ernest, Mohammed, Hisham, Guo, Hao, Stover, Daniel G, Ekram, Muhammad B, Brown, Jonathan, D'Santos, Clive, Krop, Ian E, Dillon, Deborah, McKeown, Michael, Ott, Christopher, Qi, Jun, Ni, Min, Rao, Prakash K, Duarte, Melissa, Wu, Shwu-Yuan, Chiang, Cheng-Ming, Anders, Lars, Young, Richard A, Winer, Eric, Letai, Antony, Barry, William T, Carroll, Jason S, Long, Henry, Brown, Myles, Liu, X. Shirley, Meyer, Clifford A, Bradner, James E, Polyak, Kornelia

Volltext

Why do BCL-2 inhibitors work and where should we use them in the clinic? von Montero, Joan, Letai, Antony

Volltext bestellen

Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer von Shu, Shaokun, Lin, Charles Y, He, Housheng Hansen, Witwicki, Robert M, Tabassum, Doris P, Roberts, Justin M, Janiszewska, Michalina, Huh, Sung Jin, Liang, Yi, Ryan, Jeremy, Doherty, Ernest, Mohammed, Hisham, Guo, Hao, Stover, Daniel G, Ekram, Muhammad B, Brown, Jonathan, D'Santos, Clive, Krop, Ian E, Dillon, Deborah, McKeown, Michael, Ott, Christopher, Qi, Jun, Ni, Min, Rao, Prakash K, Duarte, Melissa, Wu, Shwu-Yuan, Chiang, Cheng-Ming, Anders, Lars, Young, Richard A, Winer, Eric, Letai, Antony, Barry, William T, Carroll, Jason S, Long, Henry, Brown, Myles, Liu, X Shirley, Meyer, Clifford A, Bradner, James E, Polyak, Kornelia

Volltext bestellen